DA 001
Alternative Names: DA-001Latest Information Update: 16 Dec 2024
Price :
$50 *
At a glance
- Originator Applied Biology
- Class Anti-inflammatories; Antiacnes; Antipsoriatics; Hydantoins; Imidazolidines; Keratolytics; Skin disorder therapies; Small molecules; Urea compounds
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Trace amine-associated receptor 1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alopecia
Most Recent Events
- 22 Oct 2024 Preclinical trials in Alopecia in USA (Topical) (NCT06648850)
- 22 Oct 2024 Applied Biology plans a phase III trial for Alopecia in November 2024 (Topical) (NCT06648850)